Kidney Innovation Accelerator
Overview
Kidney Innovation Accelerator is a public-private partnership between the U.S. Department of Health and Human Services (HHS) and the American Society of Nephrology (ASN) that accelerates innovation in the prevention, diagnosis, and treatment of kidney diseases through prize competitions.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Qidni Labs | Jan 2025 | Grant | Lead |
| Trestle Biotherapeutics | Jun 2023 | Grant | Co-investor |
| NitriCap Medical | Jul 2020 | Grant | Co-investor |
| Makana Therapeutics | Jun 2023 | Grant | Co-investor |
| US Kidney Research Corporation | Nov 2021 | Grant | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Kidney Innovation Accelerator based?
Kidney Innovation Accelerator is headquartered in Washington D.C., United States.
When was Kidney Innovation Accelerator founded?
Kidney Innovation Accelerator was founded in 2018.
How many portfolio companies does Kidney Innovation Accelerator have?
Kidney Innovation Accelerator has 5 portfolio companies in Caplight's dataset.
What are some companies in Kidney Innovation Accelerator's portfolio?
Portfolio companies visible on Caplight include Qidni Labs, Trestle Biotherapeutics, NitriCap Medical, Makana Therapeutics, US Kidney Research Corporation.
What was Kidney Innovation Accelerator's most recent investment shown here?
Kidney Innovation Accelerator's most recent investment in this portfolio sample was in Qidni Labs in 2025.
What sectors does Kidney Innovation Accelerator focus on?
Kidney Innovation Accelerator focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech.
What company stages does Kidney Innovation Accelerator focus on?
Kidney Innovation Accelerator typically invests at the Early stage.